| Residential College | 否No |
| Status | 已獲得Obtained |
| Research and development of gut bacteria β-glucuronidase inhibitor MSK and its analogs derived from Chinese medicine to alleviate the gastrointestinal toxicity of anticancer drug irinotecan | |
| Alternative Title | 中藥來源的腸道菌â-葡萄糖醛酸苷酶抑制劑MSK及其類似物緩解抗癌藥伊立替康的腸毒性的研發 |
| Project Number | EF025/ICMS-YR/2022/SZSTIC |
| YAN RU | |
| Subtype | 深港澳科技計劃項目C類 |
| Project Source | 其他Others |
| 2022-04-30 | |
| End Date | 2024-04-30 |
| Funding Organization | 深圳市科技創新委員會 |
| Project Funding | 1,200,000.00 |
| Document Type | Project |
| Collection | University of Macau |
| Recommended Citation GB/T 7714 | YAN RU.Research and development of gut bacteria β-glucuronidase inhibitor MSK and its analogs derived from Chinese medicine to alleviate the gastrointestinal toxicity of anticancer drug irinotecan.2022. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment